Deep learning is reshaping clinical trial design, execution, and analysis. Learn how to deploy it safely, measurably, and at scale with help from life sciences consultant and MIT industry advisor Partha Anbil.
- Telehealth In Clinical Trials: What You Need To Know
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
ON-DEMAND WEBINARS
Here, viewers will learn about best practices for developing an effective data collection strategy and selecting technology solutions that align with research needs.
This on‑demand session offers a clear, practical overview of the major eSignature types used in eConsent — ranging from simple electronic signatures to fully qualified electronic signatures — and explains when each is appropriate.
A must for all clinical leaders, this webinar shares strategic, operational, regulatory, and financial benefits of a seamless CTMS and eTMF integration. Watch the webinar to find out why CTMS-eTMF integration has increasingly become imperative for sponsors and CROs around the world.
Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![vendor-support-clinical-trials]( "Vendor Selection Bias: Why Structured Decisions Often Fail")
Vendor Selection Bias: Why Structured Decisions Often FailLearn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
![GettyImages-1413764598 managing data]( "Empowering Freenome: Large-Scale Data Quality And Compliance")
Empowering Freenome: Large-Scale Data Quality And ComplianceDelve into five ways this biotech company was able to successfully deliver data quality and compliance for large-scale trials while developing next-generation blood tests for early cancer detection.
-
![Problem solving challenge achievement GettyImages-1271935835]( "Helping Biotechs Overcome 4 Key Challenges")
Helping Biotechs Overcome 4 Key ChallengesDelays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
-
![GettyImages-955812666 patient recruitment]( "Patient Recruitment From A Site Perspective")
Patient Recruitment From A Site PerspectiveWhen used strategically and in conjunction with traditional enrollment methods, see how technology can significantly enhance patient recruitment efforts.
-
![iStock-1002126898-graph-tablet-meeting-risks-planning]( "How A Dedicated Medical Affairs Team Drives Site Engagement")
How A Dedicated Medical Affairs Team Drives Site EngagementSee how improvements made to SIP have allowed for quick access to study documents and bulk actions for streamlined document management and enhanced user experience.
-
![GettyImages-1390654899 esource patient]( "How Capturing Data Directly Is Transforming Trials")
How Capturing Data Directly Is Transforming TrialsWith the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
-
![GettyImages-1137724859 analytics]( "How Analytics Are Shaping The Future Of Clinical Trial Risk Management")
How Analytics Are Shaping The Future Of Clinical Trial Risk ManagementExplore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.
-
![How Should Biosimilar Companies Approach Real-World Evidence?]( "Evidence Generation Evolved")
Evidence Generation EvolvedExplore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.
-
![GettyImages-635889138 target]( "Are You Aiming For The Bullseye Or Just The Target?")
Are You Aiming For The Bullseye Or Just The Target?Learn what this author has to say about focusing on a clinical trial's outcome when developing Risk-Based Quality Management strategies.
-
![Risk-GettyImages-1364371014]( "How Long Is Your RTSM Risk Mitigation List?")
How Long Is Your RTSM Risk Mitigation List?While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
RECENT NEWSLETTERS
- 03.07.26 -- February's Best In Clinical Tech — AI, eTMF & More
- 03.05.26 -- Is Your Legacy EDC Holding Back AI In Clinical Trials?
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
